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Abstract: Natural products play an important role in the development of new drugs. In this context,
the Amaryllidaceae alkaloids have attracted considerable attention in view of their unique structural
features and various biological activities. In this study, twenty-three alkaloids were identified from
Crinum amabile by GC-MS and two new structures (augustine N-oxide and buphanisine N-oxide)
were structurally elucidated by NMR. Anti-parasitic and cholinesterase (AChE and BuChE) inhibitory
activities of six alkaloids isolated from this species, including the two new compounds, are described
herein. None of the alkaloids isolated from C. amabile gave better results than the reference drugs,
so it was possible to conclude that the N-oxide group does not increase their therapeutic potential.
Keywords: Crinum amabile; augustine N-oxide; buphanisine N-oxide; biological activities
1. Introduction
Natural products play an important role in the development of new drugs [1]. For example,
between 1940 and 2014, 49% of the small molecules approved for the treatment of cancer were
developed or directly derived from natural products [1]. The isoquinoline-type alkaloids found in
the Amaryllidaceae plant family represent an interesting source of new drugs due to their diverse
biological activities [2]. The most important Amaryllidaceae alkaloid is galanthamine, which was
approved by the Food and Drug Administration (FDA) for the clinical treatment of mild to moderate
Alzheimer’s disease (AD) in 2001, due to its potential acetylcholinesterase inhibitory activity [3].
According to the most recent botanical classification, the Amaryllidaceae are now a subfamily
known as the Amaryllidoideae, which together with the Agapanthoideae and Allioideae belong
to the Amaryllidaceae family [4]. Amaryllidoideae includes 59 genera and about 850 species,
with centers of diversity in South Africa, South America, particularly in the Andean region, and in the
Mediterranean [5].
Within the Amaryllidoideae, the pantropical Crinum genus is of commercial, economical and
medicinal importance [6,7]. This genus contains approximately 65 species, which are widely distributed
in diverse habitats, including coastal areas, pans (seasonally flooded depressions), sandy and aquatic
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areas, and swamps [8]. Crinum seeds are highly buoyant, with corky, water-repellent surfaces, allowing
them to be dispersed by water [8,9]. Extracts from Crinum species have been used in folk medicine to
treat fever, pain, swelling, sores, wounds, cancer and malaria [10]. The biological activities of Crinum
species, including antitumor, immunostimulating, analgesic, antiviral, antibacterial, and antifungal,
are attributed to their alkaloid content [7,9].
Known as a decorative plant, Crinum amabile has also long been used in Vietnamese folk medicine
as an emetic and a remedy for rheumatism and earache [11]. Fifteen alkaloids have been previously
identified in C. amabile: amabiline, ambelline, augustine, buphanisine, crinamabine, crinamine,
crinidine, 4a-dehydroxycrinamabine, flexinine, galanthamine, galanthine, hippeastrine, lycorine,
narvedine and tazettine [11–13]. Among these, amabiline, augustine, buphanisine, crinamine and
lycorine have been isolated from this species and assessed for their antimalarial and cytotoxic potential,
with augustine being the most active [13].
Tropical diseases such as malaria, leishmaniasis, Chagas disease and African trypanosomiasis
affect more than one billion people and cost developing economies billions of dollars every year [14].
As these diseases prevail in areas where poverty limits access to prevention and treatment interventions,
the pharmaceutical industry has little interest in investing in tackling them by drug development [15].
On the other hand, dementia affects around 50 million citizens worldwide, 60–70% of whom suffer
from Alzheimer’s disease, for which the current clinical treatment offers only palliative effects [16,17].
Thus, all these diseases require more research on effective treatment, in which the Amaryllidaceae
alkaloids may potentially play an important role.
The aim of this work was to perform a detailed study of the alkaloid constituents of C. amabile,
utilizing spectroscopic and chromatographic methods, including GC-MS and NMR. Two new alkaloids
were isolated and chemically characterized by spectroscopic methods and twenty-three known
alkaloids were identified by GC-MS. Due to the potential of Amaryllidaceae alkaloids in the clinical
treatment of Alzheimer’s disease [3], as well as the activity of augustine against malaria [13],
we decided to check the cholinesterase-acetylcholinesterase (AChE) and butyrylcholinesterase
(BuChE)-inhibitory activities and the antiprotozoal capacity of six alkaloids isolated from C. amabile,
including the two new alkaloids. The role of N-oxide compounds in these biological activities
was explored.
2. Results and Discussion
2.1. Alkaloids Identified by GC-MS
Twenty-three known alkaloids from Crinum amabile were identified by GC–MS (Table 1 and
Figure 1) by comparison of the Rt, fragmentation patterns and spectral data using our home database.
This database was built from single alkaloids isolated and identified by spectroscopic and spectrometric
methods (NMR, UV, CD, IR, MS) in the Natural Products Laboratory, University of Barcelona, Spain.
Also used were the NIST 05 Database and literature data [18–22].
2.2. Structural Elucidation
Two new alkaloids were identified in C. amabile: augustine N-oxide (1) and buphanisine N-oxide
(2), both N-oxides of the structures augustine (13) and buphanisine (8), respectively. N-oxides occur as
natural products and are not artefacts formed during the isolation procedures [23,24]. Ungiminorine
N-oxide, homolycorine N-oxide, O-methyllycorenine N-oxide, galanthamine N-oxide, sanguinine
N-oxide, lycoramine N-oxide and undulatine N-oxide are examples of Amaryllidaceae alkaloid
N-oxides also reported as natural products [25–28].
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Table 1. Alkaloids identified in Crinum amabile by GC-MS.
Alkaloid RI M+ MS
Lycorene (3) 2102.2 255 (52) 254 (100), 227 (17), 226(20), 211 (15), 183(14),181(10)
Ismine (4) 2124.3 257 (28) 239(16), 238 (100), 196 (10),168 (10)
Demethylismine (5) 2128.8 243 (22) 225(21), 224 (100), 167 (10), 166 (15), 154 (11),77 (12)
Demethylmesembrenol (6) 2177.0 275 (5) 206 (9), 205 (76), 115 (6),70 (100)
Galanthamine (7) 2262.8 287 (85) 286 (100), 244(29), 216 (45), 174(39), 165(16), 141 (14),128 (21), 115 (31)
Buphanisine (8) 2283.7 285 (95) 273 (54), 272 (43), 254 (40), 215 (100), 157 (39), 129 (35),128 (55), 115 (64)
Sanguinine (9) 2288.3 273 (100) 272 (85), 202 (40), 165(20), 160 (50), 131 (20), 128(19),115 (28), 77(20),
Crinine (10) 2326.7 271 (100) 228 (24), 200 (30), 199(81), 187 (76), 173 (28), 129 (34),128(44), 115 (47), 56 (32)
8-O-Demethylmaritidine (11) 2373.8 273 (100) 230 (25), 202 (29), 201 (80), 189 (65), 175 (29), 129 (24),128 (30), 115 (32), 56 (30)
3-O-Acetylsanguinine (12) 2387.1 315 (37) 256 (100), 255 (42), 254 (37), 212(26), 165 (33), 152 (23),115 (30), 96 (67)
Augustine (13) 2411.6 301 (93) 228 (36), 187 (30), 175 (300), 173 (24), 159 (38), 143 (57),128 (259, 115 (75)
Buphanisine N-oxide (2) 2429.8 301 (nv) 285 (100), 270 (33), 254 (35), 216 (21), 215 (82), 201 (24),157 (20), 128 (22)
Haemanthamine (14) 2436.9 301 (55) 257 (54), 227 (80), 225 (98), 224(80), 181 (100), 153 (46),152 (46), 115 (64)
11,12-Dehydroanhydrolycorine (15) 2448.5 249 (55) 248 (100), 191 (13), 190 (31), 189 (11),95 (14)
Crinamine (16) 2497.6 273 (17) 272 (100), 242 (12), 214 (11), 186 (12),128 (15)
Hamayne (17) 2551.7 259 (14) 258 (100), 242 (11), 214 (10), 211 (12), 181 (14),128 (19)
1-O-Acetyllycorine (18) 2563.1 329 (20) 299(15), 268 (28), 250 (17), 244 (20), 227 (56),226 (100), 240 (11)
Augustine N-oxide (1) 2571.8 317 (nv) 301 (100), 228 (34), 187 (22), 175 (77), 173 (17),159 (27), 143 (37), 115 (37)
Lycorine (19) 2592.2 287 (19) 286 (13), 268 (18), 250 (10), 227 (60), 226 (100),147 (11)
Undulatine (20) 2594.4 331 (100) 258 (37), 219 (22), 217 (36), 205 (71), 203 (37),189 (43), 173 (39), 115 (35)
Ambelline (21) 2621.1 331 (69) 287 (100), 260 (81), 257 (62), 255 (74), 254 (52),241 (51), 239 (61), 211 (69)
Augustamine (22) 2628.7 301 (76) 300 (100), 245(16), 244(84), 215(33), 201 (32),188 (14), 115 (22), 70 (21)
6-Hydroxybuphanidrine (23) 2631.3 331 (35) 277 (16), 276 (100), 261 (30), 218 (17), 217 (23),216 (24), 115 (18), 56 (25)
N-Formylnorgalanthamine (24) 2649.1 301 (100) 225 (26), 211 (29), 181 (19), 165 (14), 129 (18),128 (22), 115 (30), 77 (15)
2-O-Acetyllycorine (25) 2676.2 329 (21) 328 (17), 270 (40), 269 (72), 268 (100), 252 (43),250 (73), 227 (27), 226 (67)
* not visible.
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Figure 1. Alkaloids identified in C. amabile by GC-MS.
2.2.1. Augustine N-oxide (1)
The 1H-NMR signals of compound 1 (Table 2) were consistent with the structure of augustine [29].
However, H-4α and H-4a and H-6α, H-6β, and H-12endo and H-12exo were deshielded between
1.21 and 0.36 ppm. These deshielding effects are congruent with the salt or N-oxide form of
augustine. HR-ESI-MS analysis was carri d out to confirm an additional oxygen atom in the str cture.
Compound 1 exhibited a parent [M + H]+ ion at m/z 318.1335 in its HR-ESI-MS spectrum, suggesting
the molecular formula C17H20NO5 (calcd. 318.1336) and confirming compound 1 as augustine N-oxide.
The absolute configuration of this struct t r ined by CD. The curve and shape were
qualitatively similar to those of known crini e-ty e alkaloids, with the 5,10b-ethano bridge in a
β-orientation, having a maximum of around 245 n and a ini um of 295 nm. The COSY spectrum
showed a benzylic coupling between H-7 and H-6, which allowed us to determine the H-7 proton
location in the 1H-NMR spectrum. The two C-6 protons were differentiated as an AB system with a
geminal coupling of around 15.7 Hz. H-4a showed a NOESY correlation with H-6α, which turned out to
be crucial for the assignment of its orientation. We were able to determine the H-4β orientation from the
large coupling constant between H-4a and H-4β (around 13.8 Hz), and the α-orientation of the methoxy
group at C-3 from the small constant between H-4β and H-3 (around 2.7 Hz). The β-orientation of
the epoxy group was assignable based on the low values of the H-1 and H-2 constants (3.5 and
3.2 Hz, respectively). The NOESY contour plot between H-4β and H-11exo and H-12exo allowed us to
determine the H-11exo and H-12exo locations in the 1H-NMR spectrum. The quaternary carbons C-6a,
C-10a, C-8 and C-9 were ascribed by means of their respective three-bond HMBC correlations with
H-10, H-7, H-10 and H-7. Finally, the singlet resonance signal at δ = 43.95 ppm in the 13C spectrum was
assig ed to C-10b, taking into account the thre -bo d connectivities to H-10, H-4α and H-4β (Figure 2)
in the HMBC experiment.
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Table 2. NMR data for compounds 1 and 2 (400 MHz for 1H and 100 Hz for 13C, CDCl3).
1 2
No. δC, type δH (J in Hz) δC, type δH (J in Hz)
1 52.06 3.68, d (3.5) 129.59 6.39, d (10.0)
2 55.06 3.42, ddd (3.2, 2.4, 0.7) 127.18 6.08, ddd (10.0, 5.3, 1.0)
3 73.43 4.12, dd (2.7, 2.5) 71.38 3.95, ddd (5.6, 3.6, 2.0)
4α 19.72 2.91, dt (14.1, 3.1) 23.46 3.13 ddt (13.6, 4.2, 2.4)
4β 19.72 1.54, ddd (13.8, 13.8, 2.9) 23.46 1.72 ddd (13.7, 13.7, 4.0)
4a 72.59 3.51, dd (13.4, 3.6) 74.14 3.74, dd (13.2, 4.3)
6α 67.56 4.83, dd (15.7, 1.8) 76.55 4.84, d (15.6)
6β 67.56 4.68, d (15.7) 76.55 4.72, d (15.6)
6a 122.33 - 121.71 -
7 106.40 6.57, s 106.44 6.54, s
8 147.13 - 147.20 -
9 147.79 - 147.79 -
10 102.49 6.90, s 102.98 6.81, s
10a 133.92 - 134.75 -
10b 43.95 - 46.60 -
11endo 35.64 1.99, ddd (12.4, 9.4, 5.1) 40.02 2.11, ddd (12.5, 8.0, 6.0)
11exo 35.64 2.79, ddd (12.4, 12.4, 6.9) 40.02 2.26, ddd (12.2, 10.8, 8.6)
12endo 67.56 3.81, ddd (12.8, 9.4, 7.0) 68.97 3.88, m
12exo 67.56 3.73, dddd (12.5,12.5, 5.0, 2.2) 68.97 3.85, m
OCH2O 101.58 5.99, d (1.3), 5.98 d (1.3) 101.51 5.95, d (1.3), 5.93 d (1.3)
OMe 57.92 3.47, s 57.23 3.39, s
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2.2.2. Buphanisine N-oxide (2) 
The 1H-NMR spectrum of compound 2 (Table 2) was similar to that of buphanisine [30]. 
However, the H-4α, H-4a, H-6α, H-6β, H-12endo and H-12exo protons were assigned as 0.80, 0.24, 
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exhibited a parent [M + H]+ ion at m/z 302.1385 in its HR-ESI-MS spectrum, suggesting the molecular 
formula C17H20NO4 (calcd. 302.1387) and confirming compound 2 as buphanisine N-oxide. 
The absolute configuration of this structure was determined by CD. The spectrum curve had a 
maximum of around 245 nm and a minimum of around 292 nm, confirming a crinine-type alkaloid 
with the 5,10b-ethano bridge in a β-orientation. The assignment of the aromatic protons was based 
on the benzylic coupling between H-6 and H-7 observed by a 2D COSY experiment. The 1H-NMR 
spectrum showed two doublets at δ 4.84 and 4.72 ppm with a coupling constant of around 15.6 Hz. 
The first one was assigned as H-6α due to the NOESY contour plot of the proton H-4a. The large 
coupling constant between H-4a and H-4β (around 13.7 Hz) allowed the H-4β proton location to be 
determined in the 1H-NMR spectrum. The NOESY contour plot between H-4β and H-11exo and 
H-12exo enabled us to determine their location in the 1H-NMR spectrum. In the HMBC spectrum, the 
three-bond correlations observed for H-7 to C-9, H-10 to C-8, H-7 to C-10a and H-10 to C-6a allowed 
us to identify the location of the quaternary carbons C-8, C-9, C-6a and C-10a in the 13C spectrum. 
Figure 2. Structures of the two new alkaloids elucidated from C. amabile.
2.2.2. Buphanisine N-oxide (2)
The 1H-NMR spectrum of compound 2 (Table 2) was similar to that of buphanisine [30]. However,
the H-4α, H-4a, H-6α, H-6β, H-12endo and H-12exo protons were assigned as 0.80, 0.24, 0.32, 0.82,
0.86 and 0.29 ppm more deshielded, respectively, than their homologs in buphanisine. HR-ESI-MS
analysis allowed us to confirm the presence of N-oxide in this structure. Compound 2 exhibited a
parent [M + H]+ ion at m/z 302.1385 in its HR-ESI-MS spectrum, suggesting the molecular formula
C17H20NO4 (calcd. 302.1387) and confirming compound 2 as buphanisine N-oxide.
The absolute co figuration of this structure was determined by CD. The spectrum curve had a
maximum of around 245 nm and minimum of around 292 nm, confirming a crinine-type alkaloid
with the 5,10b-ethano bridge in a β-orientation. The assignment of the aromatic protons was based
on the benzylic coupling between H-6 and H-7 observed by a 2D COSY experiment. The 1H-NMR
spectrum showed two doublets at δ 4.84 and 4.72 ppm with a coupling constant of around 15.6 Hz.
The first one was assigned as H-6α due to the NOESY contour plot of the proton H-4a. The large
coupling constant between H-4a and H-4β (around 13.7 Hz) allowed the H-4β proton location to
be determined in the 1H-NMR spectrum. The NOESY contour plot between H-4β and H-11exo and
H-12exo enabled us to determine their location in the 1H-NMR spectrum. In the HMBC spectrum,
the three-bond correlations observed for H-7 to C-9, H-10 to C-8, H-7 to C-10a and H-10 to C-6a allowed
us to identify the location of the quaternary carbons C-8, C-9, C-6a and C-10a in the 13C spectrum.
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The three-bond coupling between C-10b and H-2, H-10 and H-4 permitted its location to be assigned
at δ = 46.60 ppm in the 13C spectrum (Figure 2).
2.3. Biological Activities
The alkaloid augustine presents significant activity against chloroquine-sensitive and
chloroquine-resistant strains of Plasmodium falciparum (IC50 = 0.46 and 0.60 µM, respectively) [13].
We consequently decided to verify in vitro the activity of six alkaloids isolated from C. amabile,
augustamine (22), augustine (13), augustine N-oxide (1), buphanisine (8), buphanisine N-oxide (2) and
crinine (10), against four different protozoa, Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania
donovani and Plasmodium falciparum, which are related to sleeping sickness, Chagas disease, visceral
leishmaniasis and malaria, respectively. These alkaloids are structurally very similar, with the exception
of augustamine, which is a unique kind of Amaryllidaceae alkaloid previously isolated from other
Crinum species, including C. augustum, C. kirkii and C. latifolium [28,31,32], and completely elucidated
in 2000 [33]. The rareness of this structure motivated us to isolate it and check its biological activity.
In addition, due to the potential effectiveness of Amaryllidaceae alkaloids in the clinical treatment of
Alzheimer’s disease, the alkaloids were also tested in vitro against acetyl- and butyrylcholinesterase.
2.3.1. AChE and BuChE Inhibitory Activities
All the results for cholinesterase inhibitory activities are shown in Table 3. No tested alkaloid
presented BuChE inhibitory activity. AChE inhibitory activity was moderate in augustine (13), and low
in buphanisine (8). The structures of these two alkaloids are very similar: between C-1 and C-2
augustine (13) presents an epoxy group and buphanisine (8) an olefin group (Figure 1). Interestingly,
the augustine (13) epoxy group seems to increase the AChE inhibitory activity, more than the olefin
in buphanisine (8). The AChE inhibitory activity is also slightly improved by the presence of a
hydroxyl group at C-3, as occurs in the crinine (10) alkaloid, but not by the methoxy group in the same
substituent, as occurs in buphanisine (8). Unfortunately, the N-oxide group did not increase the AChE
inhitory activities of augustine N-oxide (1) and buphanisine N-oxide (2). Furthermore, augustamine
(22) did not show any cholinesterase inhibitory activities.
Table 3. Results of AChE and BuChE inhibitory activities of the alkaloids isolated from C. amabile.
Alkaloid AchE * BuChE *
Augustine N-oxide (1) 79.64 ± 5.26 >200
Buphanisine N-oxide (2) >200 >200
Agustamine (22) >200 >200
Augustine (13) 45.26 ± 2.11 >200
Buphanisine (8) 183.31 ± 36.64 >200
Crinine (10) 163.89 ± 15.69 >200
Galanthamine (7) 0.45 ± 0.03 3.88 ± 0.19
* all results are in µg mL−1.
2.3.2. Antiprotozoal Activity
All the alkaloids isolated from C. amabile showed low activity against all the protozoa tested
(Table 4). Buphanisine (8) showed significant inhibitory activity against the NF54 strain of P. falciparum
(with a 50% inhibitory concentration (IC50) of 4.28 ± 0.18 µg mL−1. The presence of an N-oxide
group in augustine N-oxide (1) and buphanisine N-oxide (2) appears to decrease their activity against
T. brucei and P. falciparum compared to augustine (13) and buphanisine (8), respectively. In this
experiment, the epoxy group at C-1 and C-2 probably decreases the activity of augustine (13) against
P. falciparum compared to buphanisine (8), which has a double bond between C-1 and C-2. Furthermore,
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the presence of a methoxy group at C-3 seems to increase the activity of buphanisine (8) against
P. falciparum compared to crinine (10), which has a hydroxyl group in the same position.
Table 4. In vitro antiprotozoal and cytotoxic activities of 1 and 2. Values expressed in IC50 (µg mL−1).
Parasite T. bruceirhodesiense T. cruzi L. donovani P. falciparum Cytotoxicity
Reference drug 0.003 ± 0.001 a 0.865 ± 0.08 b 0.515 ± 0.06 c 0.004 ± 0.0007 d 0.004 ± 0.0007 e
Augustine (13) 15.05 ± 1.06 56.00 ± 0.71 >100 14.20 ± 0.14 >100
Augustine N-oxide (1) 58.85 ± 11.53 66.25 ± 11.81 >100 36.65 ± 4.74 >100
Buphanisine (8) 16.5 ± 0.57 55.55 ± 4.60 >100 4.28 ± 0.18 72.85 ± 5.02
Buphanisine N-oxide (2) 55.25 ± 4.31 64.05 ± 1.34 >100 32.55 ± 0.07 >100
Crinine (10) 18.95 ± 0.78 57.45 ± 6.86 >100 30.95 ± 2.19 >100
Augustamine (22) 19.20 ± 2.97 54.00 ± 4.53 >100 20.35 ± 0.21 81.55 ± 0.64
a melarsoprol; b benznidazole; c miltefosine; d chloroquine; e podophyllotoxin.
3. Materials and Methods
3.1. Plant Material
Bulbs of Crinum amabile Donn. were collected in Vitoria (Espírito Santo, Brazil) in September
2016. The sample was authenticated by Dr. Alan Meerow at the Subtropical Horticulture Research
Station (Miami, FL, USA). A specimen voucher (VIES 39506) has been deposited in the Herbarium of
the Universidade Federal do Espirito Santo (UFES; Vitoria, Brazil).
3.2. Equipment
About 2 mg of each alkaloid extract was dissolved in 1000 µL of methanol (MeOH) and/or
chloroform (CHCl3) and injected directly into the GC-MS apparatus (Agilent Technologies, Santa
Clara CA, USA) operating in the EI mode at 70 eV. A Sapiens-X5 MS column (30 m × 0.25 mm i.d.,
film thickness 0.25 µm) was used. The temperature gradient performed was the following: 2 min at
100 ◦C, 100–180 ◦C at 15 ◦C min−1, 180–300 ◦C at 5 ◦C min−1 and 10 min hold at 300 ◦C. The injector and
detector temperatures were 250 ◦C and 280 ◦C, respectively, and the flow-rate of carrier gas (He) was
1 mL min−1. A split ratio of 1:10 was applied and the injection volume was 1 µL. The alkaloids were
identified by GC-MS and the mass spectra were deconvoluted using the software AMDIS 2.64. Kovats
retention indices (RI) were recorded with a standard calibration n-hydrocarbon mixture (C9–C36)
using AMDIS 2.64 software.
1H-NMR, 13C-NMR, COSY, NOESY, HSQC, and HMBC spectra were recorded on a Bruker
400 MHz Avance III equipped with CryoProbe Prodigy (Bruker, Billerica, MA, USA), using CDCl3
as the solvent and tetramethylsilane (TMS) as the internal standard. Chemical shifts are reported in
units of δ (ppm) and coupling constants (J) are expressed in Hz. CD, UV and IR spectra were recorded
on Jasco-J-810 (Jasco, Easton, MD, USA), Dinko UV2310 (Dinko Instruments, Barcelona, USA) and
Thermo Scientific Nicolet iN10 MX spectrophotometers (Thermo Fisher Scientific, Waltham, MA, USA),
respectively. HR-ESI-MS spectra were obtained on an LC/MSD-TOF (2006) mass spectrometer (Agilent
Technologies) operating in the positive mode, applying 4 kV in the capillary, 175 V in the fragmentor, a
gas temperature of 325 ◦C, and N2 as the nebulizing gas (15 psi) and drying gas (flow = 7.0 L min−1).
Silica gel SDS chromagel 60 A CC (6–35 µm) was used for VLC, and silica gel 60 F254 (Merck, Darmstadt,
Germany) for analytics and prep. Spots on chromatograms were detected under UV light (254 nm)
and by Dragendorff’s reagent stain.
3.3. Extraction
Fresh bulbs (2.2 kg) and leaves (1.3 kg) of C. amabile were collected and macerated with MeOH
(3 × 1.0 L) at room temperature for 4 days. The combined macerate was filtered and the solvent
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evaporated to dryness under reduced pressure. The bulb and leaf crude extracts (485 and 390 g,
respectively) were then acidified to pH 3 with diluted sulfuric acid, H2SO4 (2%, v/v). The neutral
material was removed with Et2O (3 × 200 mL) and extracted with ethyl acetate (EtOAc) (3 × 200 mL)
to obtain the acid EtOAc extracts (4.58 and 2.8 g, respectively). The aqueous solutions were basified
up to pH 9–10 with ammonium hydroxide, NH4OH (25%, v/v) and extracted with n-hexane, n-Hex
(3 × 150 mL) to give the n-Hex extracts (1.16 and 0.40 g, respectively, and finally extracted with EtOAc
(2 × 200 mL) to obtain the EtOAc extracts (5.11 and 1.15 g, respectively).
The extracts were subjected to a combination of chromatographic techniques, including vacuum
liquid chromatography (VLC) [34], Sephadex, thin layer chromatography (TLC) and semi-preparative
TLC. The VLC is an effective methodology to rapidly and inexpensively separate large or small
quantities of compounds from extracts [35]. A silica gel 60 A (6–35 µm) column was used with a height
of 4 cm and a variable diameter according to the amount of sample (2.5 cm for 400–1000 mg; 1.5 cm for
150–400 mg). Alkaloids were eluted with n-Hex containing increasing EtOAc concentrations, followed
by neat EtOAc, which was gradually enriched with MeOH (reaching a maximum concentration
of 20%, v/v). Fractions of 10–15 mL were collected, monitored by TLC (UV 254 nm, Dragendorff’s
reagent), and combined according to their profiles. For semi-preparative TLC, silica gel 60F254 was used
(20 cm × 20 cm × 0.25 mm) together with different solvent mixtures depending on each particular
sample (EtOAc:MeOH, 9:1, v/v; EtOAc:MeOH, 8:2, v/v; or EtOAc:CHCl3:MeOH, 6:4:2, v/v/v), always in
an environment saturated with ammonia. The alkaloids were each identified by GC-MS and the two
new alkaloids had their structure elucidated by NMR.
Exclusion chromatography was carried out using a Sephadex LH-20 column (2.5 cm × 40 cm) to
clean and separate the alkaloids in the n-Hex bulb extract (1.16 g). It was eluted with 100% MeOH,
producing 52 fractions, each one containing about 2 mL, which were monitored by TLC and grouped
in four fractions. Fraction 3 (1.00 g) was subjected to a VLC column (2.5 cm × 4.0 cm), starting the
elution with 100% n-Hex, and gradually increasing the polarity by adding concentrations of EtOAc
up to 100%. The MeOH percentage in the mixture was then increased up to a ratio of EtOAc:MeOH
(80:20, v/v) and finally, keeping the MeOH percentage stable, the EtOAc percentage was decreased
and the CHCl3 percentage increased to a ratio of EtOAc:MeOH:CHCl3 (60:20:40, v/v/v). 48 fractions
(100 mL each) were collected, analyzed by TLC and grouped in twelve fractions.
Fraction B (28.5 mg) - eluted with n-Hex:EtOAc (eluted with 70:30 until 60:40, v/v), fraction D
(26.1 mg)-eluted with n-Hex: EtOAc (40:60, v/v), fraction F (40.0 mg) - eluted with EtOAc:MeOH (eluted
with 96:4 until 92:8, v/v), fraction H (10.5 mg) - eluted with EtOAc:MeOH (eluted with 88:12 until 83:17,
v/v) and fraction J (25.0 mg) - eluted with EtOAc:MeOH:CHCl3 (eluted with 80:20:0 until 71:20:9, v/v/v)
were subject to different semi-preparative TLC using a mobile phase consisting of EtOAc:MeOH:CHCl3
(60:20:40, v/v/v) in an environment saturated with ammonia. 12.0 mg of augustamine (22) was isolated
from fraction B, 9.1 mg of augustine (13) from fraction D, 6.0 mg of buphanisine (8) from fraction F,
2.9 mg of crinine (10) from fraction H, and 4.0 mg of augustine N-oxide (1) and 12.0 mg of buphanisine
N-oxide (2) from fraction J.
3.4. Characterization of Compounds
Augustine N-oxide (1): Amorphous solid; [α]22D −24.0 (c 0.001, CHCl3); UV (MeOH) λmax (log ε):
292.0 (3.69), 240.5 (5.57) nm; CD (MeOH, 20 ◦C) ∆ε245 + 5739, ∆ε295 −5169; IR vmax 3363, 2986, 2851,
1740, 1504, 1489, 1464, 1391, 1374, 1241, 1147, 1079, 1034, 926, 846 and 814 cm−1; 1H-NMR (CDCl3,
400 MHz) and 13C-NMR (CDCl3, 100 MHz) see Table 2; ESI-MS data shown in Table 1; HR-ESI-MS of
[M + H]+ m/z 318.1335 (calcd. for C17H20NO5, 318.1336).
Buphanisine N-oxide (2): Amorphous solid; [α]22D −1.0 (c 0.001, CHCl3); UV (MeOH) λmax (log ε):
292.0 (3.57), 240.5 (3.45) nm; CD (MeOH, 20 ◦C) ∆ε245 + 7271, ∆ε292 −7223; IR vmax 3350, 3037, 2977,
2824, 1652, 1488, 1402, 1377, 1255, 1241, 1097, 1071, 1034, 966, 931 and 854 cm−1; 1H-NMR (CDCl3,
400 MHz) and 13C-NMR (CDCl3, 100 MHz) see Table 2; ESI-MS data shown in Table 1; HR-ESI-MS of
[M + H]+ m/z 302.1385 (calcd. for C17H20NO4, 302.1387).
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3.5. Biological Activities
3.5.1. Antiprotozoal Activities
In vitro tests for the biological activity of the alkaloids isolated from C. amabile against Trypanosoma
brucei rhodesiense (trypomastigotes forms, STIB 900 strain), Trypanosoma cruzi (axenic grown amastigotes
forms, Tulahuen C4 strain), Leishmania donovani (amastigotes forms, MHOM-ET-67/L82 strain),
and Plasmodium falciparum (intraerythrocytic forms, IEF, NF54 strain) and a cytotoxicity test against the
mammalian L6 cell line from rat skeletal myoblasts were carried out at the Swiss Tropical and Public
Health Institute (Swiss TPH, Basel, Switzerland) according to established protocols as described by
Orhan and co-workers [36]. The reference drugs used in these assays were melarsoprol, benznidazole,
miltefosine, chloroquine and podophyllotoxin, respectively.
3.5.2. Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activities
Cholinesterase inhibitory activities were analyzed as by Ellman and co-workers [37] with some
modifications as by López and co-workers [38]. Fifty microliters of AChE or BuChE phosphate buffer
(8m M K2HPO4, 2.3 mM NaH2PO4, 0.15 M NaCl, pH 7.5) and 50 µL of the sample dissolved in the
same buffer were added to the wells. The plates were incubated for 30 min at room temperature
before 100 µL of the substrate solution (0.1 M Na2HPO4, 0.5 M DTNB, and 0.6 mM acetylthiocholine
iodide, ATCI, or 0.24 mM butyrylthiocholine iodide, BTCI, in Millipore water, pH 7.5) was added.
The absorbance was read in a Labsystem microplate reader (Helsinki, Finland) at 405 nm after
10 min. Galanthamine served as positive control. In a first step, samples were assessed at 10, 100 and
200 µg mL−1 towards both enzymes. Samples with an IC50 > 200 µg mL−1 were considered inactive.
Samples with an IC50 < 200 µg mL−1 were further analyzed to determine the IC50 values. Enzyme
activity was calculated as a percentage compared to an assay using a buffer without any inhibitor.
The cholinesterase inhibitory data were analyzed with the software Microsoft Office Excel 2010.
4. Conclusions
Twenty-five alkaloids were identified in C. amabile, including two new alkaloids, augustine
N-oxide and buphanisine N-oxide. This is the first time that augustamine and N-oxide structures have
been described in this species. These alkaloids, together with augustine, buphanisine and crinine,
were isolated, but none showed remarkable biological activity.
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